Essex Investment Management’s Purple Biotech PPBT Stock Holding History

Essex Investment Management’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9	Closed	-$47K	–	427
2018 Q2	$47K	Buy	+9	New	+$45K	0.01%	392

Other funds holding PPBT

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Essex Investment Management's PPBT Position: Q3 2018 in Review

Essex Investment Management sold out of Purple Biotech (PPBT) in Q3 2018, closing a stake of 9 shares — an estimated $47K sold.

Essex Investment Management first reported a position in PPBT in Q2 2018 and held it in 1 quarter. The position peaked at $47K in Q2 2018. 6 funds tracked by Wall St. Rank hold PPBT as of Q3 2018.

Essex Investment Management reported no remaining Purple Biotech position as of Q3 2018 after selling out during the quarter.
Essex Investment Management sold 9 Purple Biotech shares in Q3 2018, an estimated $47K.
Essex Investment Management first reported a position in Purple Biotech in Q2 2018 and held it in 1 quarter.
Essex Investment Management's Purple Biotech position peaked at $47K in Q2 2018.
6 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2018.

Based on Essex Investment Management's 13F filing for Q3 2018, filed 16 Oct 2018.